Table A5.
Resistance rates for A. baumannii per ward per antibiotic during the 2 years (2017–2018).
| A. baumannii | Int. Med. A | Pulm. A | Pulm. B | ICU |
|---|---|---|---|---|
| Amikacin | 90.00% | 89.77% | 80.00% | 97.27% |
| Ampicillin/sulbactam | 94.20% | 88.64% | 87.88% | 96.79% |
| Cefepime | 94.20% | 89.66% | 85.94% | 98.89% |
| Cefotaxime | 98.28% | 90.70% | 90.63% | 99.43% |
| Ceftazidime | 97.14% | 89.77% | 89.23% | 98.37% |
| Ciprofloxacin | 94.92% | 90.80% | 87.30% | 98.89% |
| Colistin | 30.56% | 26.14% | 37.50% | 53.37% |
| Gentamicin | 95.59% | 88.24% | 82.54% | 98.33% |
| Imipenem | 94.74% | 93.83% | 91.84% | 100.00% |
| Levofloxacin | 97.06% | 90.24% | 83.08% | 98.84% |
| Meropenem | 92.86% | 89.66% | 84.62% | 98.91% |
| Minocycline | 83.33% | 86.25% | 72.31% | 84.27% |
| Tobramycin | 80.82% | 86.05% | 79.69% | 94.57% |
| TMP/SMX | 90.00% | 88.64% | 87.69% | 90.53% |